Waters and BioInfra create the ASEAN Academy for Bioanalysis to promote the development of analytical skills

Seoul, South Korea–(BUSINESS WIRE)–Waters Corporation (NYSE: WAT) announced a collaboration with BioInfra, a pioneering contract research organization (CRO) for pharmaceutical and clinical fields, to jointly establish the ASEAN Academy for Bioanalysis. The academy is dedicated to providing scientists with the practical knowledge needed to design and perform a variety of bioanalytical methods, which are essential at every stage of drug discovery and development.

“There is a growing need for contract research organizations (CROs), pharmaceutical companies and regulators in the region to have access to the bioanalytical training necessary to perform drug equivalence testing for drug approval. generic drugs,” said David Curtin, vice president of Waters. Asia Pacific. “Our vision is that the training provided at the ASEAN Academy will help develop generic drug manufacturing in the region and, in turn, provide lower cost prescription drug options to people across Asia. of the Southeast.”

Located at BioInfra’s headquarters in Seoul, the ASEAN Academy for Bioanalysis will provide hands-on training using Waters’ latest analytical instruments and software. Interns will focus on the bioanalytical aspect of bioequivalence testing to ensure they are conducted in accordance with applicable principles of Good Laboratory Practice (GLP).

Bioanalytical methods used today require samples to be well characterized, fully validated and documented to yield reliable results that can be satisfactorily interpreted. These skills will help improve regional scientific competitiveness and the quality of pharmaceutical research and testing needed to meet the region’s growing demands for access to clinical trials and generic medicines, which are fueled by growing populations. older people with acute and chronic illnesses.

“We are delighted to partner with Waters Corporation in establishing the ASEAN Academy for Bioanalysis,” said Sang Deuk Lee, CEO of BioInfra. “By providing the Southeast Asian scientific community with a much-needed resource for bioanalytical training, we are further supporting BioInfra’s mission to create a healthy future for all, regardless of age or economic status.

The ASEAN Academy for Bioanalysis organizes group trainings by appointment only. Please contact JC Ahn at BioInfra for more information on training details, dates and pricing.

About BioInfra

BioInfra was established in 2007 and is a leading Contract Research Organization (CRO) with excellent professionalism in the field of bioanalysis and rich experiences and know-how in standardization of experimental processes and error control.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered innovations in chromatography, mass spectrometry and thermal analysis serving the life sciences, materials and food for over 60 years. With over 7,800 employees worldwide, Waters operates directly in over 35 countries, including 14 manufacturing plants, and with products available in over 100 countries.

Waters is a trademark of Waters Corporation.